Smoking cessation
311 results
1 - 100
Aversive smoking for smoking cessation- Competitions for smoking cessation
- Mindfulness for smoking cessation
- Nicobrevin for smoking cessation
- Anxiolytics for smoking cessation
- Lobeline for smoking cessation
- Smoking reduction interventions for smoking cessation
- Clonidine for smoking cessation
- Antidepressants for smoking cessation
- Hypnotherapy for smoking cessation
- Incentives for smoking cessation
- Exercise interventions for smoking cessation
- Motivational interviewing for smoking cessation
- Workplace interventions for smoking cessation
- Silver acetate for smoking cessation
- Nicotine vaccines for smoking cessation
- System change interventions for smoking cessation
- Nursing interventions for smoking cessation
- Physician advice for smoking cessation
- Opioid antagonists for smoking cessation
- Interventions for waterpipe smoking cessation
- Mecamylamine (a nicotine antagonist) for smoking cessation
- Quit and Win contests for smoking cessation
- Individual behavioural counselling for smoking cessation
- Training health professionals in smoking cessation
- Acupuncture and related interventions for smoking cessation
- Telephone counselling for smoking cessation
- Community pharmacy personnel interventions for smoking cessation
- Interventions for smoking cessation in hospitalised patients
- Real‐time video counselling for smoking cessation
- Smoking cessation for improving mental health
- Biomedical risk assessment as an aid for smoking cessation
- Interventions for smoking cessation and reduction in individuals with schizophrenia
- Enhancing partner support to improve smoking cessation
- Internet‐based interventions for smoking cessation
- Strategies to improve smoking cessation rates in primary care
- Interventions for smoking cessation in people diagnosed with lung cancer
- Smoking cessation advice for people with serious mental illness
- Group behaviour therapy programmes for smoking cessation
- Pharmacological interventions for promoting smoking cessation during pregnancy
- Smoking cessation for chronic obstructive pulmonary disease
- Smoking cessation interventions for smokers with current or past depression
- Smoking cessation for secondary prevention of cardiovascular disease
- Heated tobacco products for smoking cessation and reducing smoking prevalence
- Smoking cessation interventions for pulmonary tuberculosis treatment outcomes
- Use of electronic health records to support smoking cessation
- Combined pharmacotherapy and behavioural interventions for smoking cessation
- Interventions for preoperative smoking cessation: Cochrane systematic review
- Electronic cigarettes for smoking cessation
- Nicotine receptor partial agonists for smoking cessation
- Interventions for preventing weight gain after smoking cessation
- Behavioural interventions for smoking cessation: an overview and network meta‐analysis
- Mobile phone text messaging and app‐based interventions for smoking cessation
- Mass media interventions for smoking cessation in adults
- Smoking cessation for people with chronic obstructive pulmonary disease
- Relapse prevention interventions for smoking cessation
- Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation
- Cannabinoid type 1 receptor antagonists for smoking cessation
- Stage‐based interventions for smoking cessation
- Psychosocial interventions for smoking cessation in patients with coronary heart disease
- Smoking cessation for the secondary prevention of coronary heart disease
- Print‐based self‐help interventions for smoking cessation
- Nicotine replacement therapy versus control for smoking cessation
- Interventions for smoking cessation in Indigenous populations: Cochrane systematic review
- Smoking cessation intervention for reducing disease activity in chronic autoimmune inflammatory joint diseases
- Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers
- Pharmacological interventions for smoking cessation: an overview and network meta‐analysis
- Differences in the effectiveness of individual‐level smoking cessation interventions by socioeconomic status
- Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation
- Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta‐analyses